title: Interventions for non-metastatic squamous cell carcinoma of the skin.
abstract: BACKGROUND
  Squamous cell carcinoma (SCC) is the second most common skin cancer, and is becoming increasingly common around the world. Left untreated, it may spread to other parts of the body, and, although the risk is low, it may ultimately lead to death. Surgical excision is the first line of treatment for most skin SCCs, although other forms of treatment are also used depending upon the nature and site of the tumour and individual participant factors. A multi-professional approach is therefore required for the management of people with this condition.
  
  
  OBJECTIVE
  To assess the effects of treatments for primary non-metastatic squamous cell carcinoma of the skin.
  
  
  METHODS
  In February 2010 we searched for relevant trials in The Cochrane Skin Group Specialised Register, The Cochrane Library (Issue 1, 2010), MEDLINE, EMBASE, PsycINFO, AMED, LILACS, and the ongoing trials registries.
  
  
  METHODS
  We only included randomised controlled trials (RCTs) of interventions for primary SCC of the skin. Inclusion criteria were: adults with one or more histologically proven primary SCCs of the skin which had not metastasised. The primary outcome measures were time to recurrence one to five years after treatment, and quality of life. Secondary outcomes included early treatment failure within six months, number of adverse events by the end of treatment, aesthetic appearance as assessed by the participant and clinician, discomfort to the participant during and after treatment, and death.
  
  
  METHODS
  Two authors (LL, FB-H) independently carried out study selection and assessment of methodological quality and data extraction.
  
  
  RESULTS
  One trial involving 65 people was included. This compared the time to recurrence in participants with aggressive skin SCC who were randomised to receive either adjuvant 13-cis-retinoic acid and interferon alpha after surgery with or without radiation treatment, or no adjuvant therapy after their initial treatment. There was no significant difference in time to recurrence of tumour between the two groups (hazard ratio 1.08, 95% confidence intervals 0.43 to 2.72).Most studies identified from the searches were excluded as they were either uncontrolled case series, did not include participants with invasive primary SCC, or included only participants with recurrent or metastatic disease.
  
  
  CONCLUSIONS
  Little evidence from RCTs comparing the efficacy of different interventions for primary cutaneous SCCs exists. There is a clear need for well-designed randomised studies in order to improve the evidence base for the management of this condition.
authors.affiliation: Centre of Evidence Based Dermatology, The University of Nottingham, King's Meadow Campus, Lenton Lane, Nottingham, UK, NG7 2NR.
authors.forename: Louise
authors.initials: L
authors.lastname: Lansbury
authors.forename: Jo
authors.initials: J
authors.lastname: Leonardi-Bee
authors.forename: William
authors.initials: W
authors.lastname: Perkins
authors.forename: Timothy
authors.initials: T
authors.lastname: Goodacre
authors.forename: John A
authors.initials: JA
authors.lastname: Tweed
authors.forename: Fiona J
authors.initials: FJ
authors.lastname: Bath-Hextall
mesh_terms: D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D012878:Skin Neoplasms / Q000473:pathology / Q000517:prevention & control / Q000628:therapy*
references.citation: J Am Acad Dermatol. 1994 May;30(5 Pt 1):774-8
references.pmid: 8176018
references.citation: Dermatol Surg. 2002 Mar;28(3):268-73
references.pmid: 11896781
references.citation: N Engl J Med. 1979 Dec 27;301(26):1410-2
references.pmid: 514321
references.citation: J Am Acad Dermatol. 1992 Jun;26(6):976-90
references.pmid: 1607418
references.citation: Br J Dermatol. 2002 Nov;147(5):950-6
references.pmid: 12410706
references.citation: Br J Dermatol. 2000 Dec;143(6):1224-9
references.pmid: 11122025
references.citation: Med J Aust. 2006 Jan 2;184(1):6-10
references.pmid: 16398622
references.citation: Hautarzt. 1989 Dec;40(12):774-7
references.pmid: 2695500
references.citation: Arch Dermatol. 1995 Feb;131(2):164-9
references.pmid: 7857112
references.citation: J Otolaryngol. 2007 Jun;36(3):148-55
references.pmid: 17711768
references.citation: Br J Dermatol. 1986 Dec;115(6):649-55
references.pmid: 3801305
references.citation: Br Med J. 1976 Jan 24;1(6003):188-90
references.pmid: 55288
references.citation: J Clin Oncol. 2001 Jan 1;19(1):231-8
references.pmid: 11134217
references.citation: Public Health Rep (1896). 1961 Apr;76:345-8
references.pmid: 13685076
references.citation: J Eur Acad Dermatol Venereol. 2003 Nov;17 Suppl 3:1-498
references.pmid: 14519105
references.citation: J Clin Oncol. 1984 Jul;2(7):756-61
references.pmid: 6376719
references.citation: J Am Acad Dermatol. 1987 Aug;17(2 Pt 1):233-8
references.pmid: 3624562
references.citation: Transplantation. 2000 Nov 27;70(10):1479-84
references.pmid: 11118094
references.citation: J Am Acad Dermatol. 1989 Aug;21(2 Pt 1):241-8
references.pmid: 2768574
references.citation: J Am Acad Dermatol. 2006 Nov;55(5):741-60; quiz 761-4
references.pmid: 17052479
references.citation: BMJ. 1996 May 11;312(7040):1215-8
references.pmid: 8634569
references.citation: Am J Epidemiol. 1996 Dec 1;144(11):1034-40
references.pmid: 8942434
references.citation: J Invest Dermatol. 2003 Aug;121(2):252-8
references.pmid: 12880415
references.citation: J Invest Dermatol. 2005 Mar;124(3):505-13
references.pmid: 15737190
references.citation: Transplantation. 1996 Mar 15;61(5):715-21
references.pmid: 8607173
references.citation: Am J Clin Oncol. 1991 Apr;14(2):133-41
references.pmid: 1903023
references.citation: J Natl Cancer Inst. 2006 Mar 15;98(6):389-95
references.pmid: 16537831
references.citation: N Engl J Med. 2001 Mar 29;344(13):975-83
references.pmid: 11274625
references.citation: J Ir Med Assoc. 1969 Feb;62(380):41-6
references.pmid: 4895865
references.citation: Lancet. 1995 Aug 12;346(8972):403-6
references.pmid: 7623570
references.citation: J Clin Oncol. 2007 May 20;25(15):1974-8
references.pmid: 17513803
references.citation: JAMA. 1995 Feb 1;273(5):408-12
references.pmid: 7823387
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Mar;9(3):291-7
references.pmid: 10750668
references.citation: Wien Med Wochenschr. 1968 Jan 13;118(2):34-6
references.pmid: 5667723
references.citation: Cancer. 1976 Jul;38(1):8-12
references.pmid: 59628
references.citation: J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):177-86
references.pmid: 10025742
references.citation: Int J Cancer. 1998 Nov 23;78(5):587-93
references.pmid: 9808527
references.citation: Cancer. 1983 Jun 15;51(12 Suppl):2448-52
references.pmid: 6850522
references.citation: Cochrane Database Syst Rev. 2007 Jan 24;(1):CD003412
references.pmid: 17253489
references.citation: Transplantation. 1990 Mar;49(3):506-9
references.pmid: 2316011
references.citation: Circulation. 1981 Oct;64(4):669-73
references.pmid: 7023743
references.citation: N Engl J Med. 1992 Dec 3;327(23):1649-62
references.pmid: 1435901
references.citation: Lancet. 1996 Mar 16;347(9003):735-8
references.pmid: 8602006
references.citation: Arch Pathol Lab Med. 2003 May;127(5):589-92
references.pmid: 12708903
references.citation: Br J Dermatol. 2002 Apr;146 Suppl 61:1-6
references.pmid: 11966724
references.citation: J Photochem Photobiol B. 2001 Oct;63(1-3):8-18
references.pmid: 11684447
references.citation: J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):467-84
references.pmid: 1564155
references.citation: JAMA. 1989 Oct 20;262(15):2097-100
references.pmid: 2795783
references.citation: Arch Dermatol. 1993 Oct;129(10):1286-90
references.pmid: 8215493
references.citation: J Invest Dermatol. 2002 Jun;118(6):1038-43
references.pmid: 12060400
references.citation: J Biomed Sci. 2006 Sep;13(5):657-66
references.pmid: 16807664
references.citation: Arch Dermatol. 1986 Oct;122(10):1124-6
references.pmid: 3767398
references.citation: Br J Plast Surg. 1987 Nov;40(6):598-604
references.pmid: 3690092
references.citation: Br J Dermatol. 2006 Mar;154(3):498-504
references.pmid: 16445782
references.citation: Surgery. 1980 Feb;87(2):177-83
references.pmid: 6986671
references.citation: Cancer. 1995 Jan 15;75(2 Suppl):667-73
references.pmid: 7804993
references.citation: Arch Dermatol. 1961 Oct;84:623-9
references.pmid: 14485715
references.citation: Arch Dermatol. 2004 Jan;140(1):26-32
references.pmid: 14732656
references.citation: J Am Acad Dermatol. 1981 Nov;5(5):535-43
references.pmid: 7298919
references.citation: Stat Med. 1998 Dec 30;17(24):2815-34
references.pmid: 9921604
references.citation: Epidemiology. 2007 Nov;18(6):776-84
references.pmid: 17917604
references.citation: J Surg Oncol. 1976;8(1):35-42
references.pmid: 55523
references.citation: Dermatol Surg. 1996 Mar;22(3):217-26
references.pmid: 8599733
references.citation: Br J Dermatol. 2002 Jan;146(1):18-25
references.pmid: 11841362
references.citation: Cancer Lett. 1991 Sep;59(3):183-92
references.pmid: 1913614
references.citation: Curr Opin Infect Dis. 2002 Apr;15(2):101-14
references.pmid: 11964909